Emcure Pharmaceuticals Ltd.
EMCURE
Clasificación en acciones
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Precio por acción
$19.06
Capitalización bursátil
$3.62B
Cambio (1 día)
-1.83%
Cambio (1 año)
20.50%
País
IN
Comercio Emcure Pharmaceuticals Ltd. (EMCURE)
Categoría
Healthcare
EPS de Emcure Pharmaceuticals Ltd. (EMCURE)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Emcure Pharmaceuticals Ltd., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Emcure Pharmaceuticals Ltd. desde 2025 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2025 | $0.01 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
